1-3 of 3
Claus-Rainer Bartram
Close
Sort by
Journal Articles

Adult patients with acute lymphoblastic leukemia and molecular failure display a poor prognosis and are candidates for stem cell transplantation and targeted therapies

Clinical Trials & Observations
Nicola Gökbuget, Michael Kneba, Thorsten Raff, Heiko Trautmann, Claus-Rainer Bartram, Renate Arnold, Rainer Fietkau, Mathias Freund, Arnold Ganser, Wolf-Dieter Ludwig, Georg Maschmeyer, Harald Rieder, Stefan Schwartz, Hubert Serve, Eckhard Thiel, Monika Brüggemann, Dieter Hoelzer
Journal: Blood
Blood (2012) 120 (9): 1868–1876.
https://doi.org/10.1182/blood-2011-09-377713
Published: 2012
Includes: Supplemental data
Journal Articles

New Definition of Treatment Response in Adult Acute Lymphoblastic Leukemia (ALL): Use of Molecular Markers for Minimal Residual Disease (MRD).

Nicola Goekbuget, MD, Monika Brueggemann, MD, Renate Arnold, MD, Claus-Rainer Bartram, PhD, Rainer Fietkau, MD, Mathias Freund, MD, Arnold Ganser, MD, Michael Kneba, MD, PhD, Thomas Lipp, MD, Wolf-Dieter Ludwig, MD, Georg Maschmeyer, MD, Dorle Messerer, Thorsten Raff, MD, Harald Rieder, MD, Eckhard Thiel, Dieter Hoelzer, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 90.
https://doi.org/10.1182/blood.V114.22.90.90
Published: 2009
Journal Articles

Significance of Copy Number Alterations for Molecular Treatment Response in Childhood Acute Lymphoblastic Leukemia.

Doris Steinemann, Dr.rer.nat., Gunnar Cario, Dr.med., Martin Stanulla, Dr.med., Leonid Karawajew, Dr.med., Marcel Tauscher, Anja Weigmann, Dr.rer.nat., Gudrun Göhring, Dr.med., Wolf-Dieter Ludwig, Dr.med., Jochen Harbott, Dr.med., Bernhard Radlwimmer, Dr.rer.nat., Claus-Rainer Bartram, Dr.med., Peter Lichter, Dr.rer.nat., Martin Schrappe, Dr.med., Brigitte Schlegelberger, Dr.med.
Journal: Blood
Blood (2007) 110 (11): 1434.
https://doi.org/10.1182/blood.V110.11.1434.1434
Published: 2007